Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foscarnet for CMV retinitis in AIDS patients
NCT00000697Phase 2Withdrawn
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of foscarnet sodium in cytomegalovirus retinitis, sponsored by National Institute of Allergy and Infectious Diseases. Status: withdrawn.
02
Drugs
foscarnet sodium
03
Conditions
cytomegalovirus retinitis
Beyond the preview
Go deeper on NCT00000697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000697.